Does Myelofibrosis Qualify for SSDI Disability Benefits?

Myelofibrosis is one of the more serious blood cancers recognized by the Social Security Administration, and it frequently appears in SSDI claims. But "frequently appears" isn't the same as "automatically approved." Whether myelofibrosis leads to a successful disability claim depends on how the condition affects your ability to work — and how thoroughly that impact is documented.

What Myelofibrosis Is and Why SSA Takes It Seriously

Myelofibrosis is a rare bone marrow cancer that disrupts normal blood cell production. Scar tissue replaces healthy marrow, leading to severe anemia, an enlarged spleen, fatigue, bone pain, and increased infection risk. Advanced cases can progress to acute leukemia.

Because myelofibrosis is a malignant neoplasm — a form of cancer — SSA evaluates it under its Hematological Disorders listings, specifically Listing 13.06 in the Blue Book, SSA's official medical criteria manual. Meeting a listing is one of two main paths to approval.

The Blue Book Listing Path

SSA's Listing 13.06 covers chronic myelogenous leukemia and related myeloproliferative disorders. To meet this listing, the medical evidence generally needs to show:

• Accelerated or blast phase disease, or
• Conditions that are refractory to treatment (meaning the disease doesn't respond adequately to medical intervention), or
• Complications — such as recurrent infections, hemorrhage, or other serious outcomes — that are severe and persistent

Meeting a listing means SSA considers you disabled without needing to assess your ability to work. This is a faster path, but the medical threshold is specific. Early-stage or well-managed myelofibrosis may not meet the listing criteria, even though the condition is genuinely serious.

When the Listing Isn't Met: The RFC Path 🩺

Many SSDI claimants with myelofibrosis don't meet the exact listing criteria — particularly those in earlier stages of the disease or whose condition is partially stabilized by treatment. That doesn't end the evaluation.

SSA then assesses your Residual Functional Capacity (RFC) — essentially, what work-related activities you can still do despite your condition. This is where individual circumstances become critical.

Myelofibrosis commonly causes:

• Profound fatigue and weakness (from anemia)
• Pain from an enlarged spleen or bone involvement
• Frequent medical appointments and treatment side effects
• Immune suppression leading to recurring illness

If these functional limitations are well-documented, SSA must determine whether you can still perform your past work, or any other work that exists in significant numbers in the national economy. That determination depends heavily on your age, education, and work history.

The Work Credits Requirement

SSDI is not a needs-based program — it's an earned benefit. To be eligible, you must have accumulated enough work credits through Social Security-taxed employment. In general, you need 40 credits, with 20 earned in the 10 years before your disability began (though younger workers need fewer).

If you don't meet the work credit requirement, SSI (Supplemental Security Income) may be an alternative. SSI is needs-based and has income and asset limits, but it uses the same medical disability standard. Both programs are worth understanding if you're evaluating your options.

The Application Process and What to Expect

Most SSDI claims follow this path:

1. Initial application — Filed online, by phone, or in person. Decision typically takes 3–6 months.
2. Reconsideration — If denied, you can request reconsideration. Approval rates at this stage are historically low.
3. ALJ Hearing — A hearing before an Administrative Law Judge. This is where many claims are ultimately decided, and where thorough medical documentation matters most.
4. Appeals Council / Federal Court — Further appeal options if the ALJ denies the claim.

For conditions like myelofibrosis, Compassionate Allowances (CALs) may apply. SSA maintains a list of severe conditions — including some hematological cancers — that can fast-track the initial review. Whether myelofibrosis in a specific form and stage qualifies for CAL processing depends on how the claim is presented.

What Medical Evidence Supports a Stronger Claim

Strong claims for myelofibrosis typically include:

• Pathology reports and bone marrow biopsy results
• Lab work showing degree of anemia or cytopenia
• Oncologist treatment notes documenting disease progression and response
• Functional assessments from treating physicians describing limitations on walking, lifting, concentration, and attendance
• Records of hospitalizations or treatment complications

SSA's Disability Determination Services (DDS) reviewers look for a clear, consistent medical record. Gaps in treatment or sparse documentation can weaken an otherwise valid claim.

How Different Profiles Lead to Different Outcomes

A claimant with blast-phase myelofibrosis and documented treatment failure has a meaningfully different claim profile than someone in an early, managed phase of the disease. Similarly, a 58-year-old with a history of manual labor faces a different grid-rule analysis than a 35-year-old with transferable sedentary skills.

Neither profile is automatically approved or denied — but the variables compound quickly. The severity of your specific disease presentation, your treatment history, your functional limitations, your age, and your work record all interact within SSA's evaluation framework. ⚖️

The medical facts of myelofibrosis may point strongly toward disability. Whether they translate to an approved SSDI claim is a question the evidence in your specific file will answer.